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Summary 
Objectives: To compare the therapeutic effects of two brands of Paracetamol: Panadol®  
(paracetamol 1000mg) and Panadol-Extra®( paracetamol 1000mg and 60mg caffeine) on 
the perception of dental pain. Method: The setting for the study was the Oral Diagnosis 
Unit of the Dental Hospital, Obafemi Awolowo University Teaching Hospitals’ Complex, 
Ile-Ife, Osun State, Nigeria. The Experimental design was a single blind quasi-
experimental repeated measure. Twenty volunteers with healthy permanent upper right 
central incisors were the subjects of the study. Using the Digitest Pulp Vitality Tester as a 
stimulator, the pain thresholds of the right maxillary central incisors were detected. 
Subjects were then given 1000mg of paracetamol (Panadol®) or 1000mg of paracetamol 
and 60 mg caffeine (Panadol - Extra®) orally and the pain thresholds were again detected 
and recorded at 30. 60, 90 and 120 minutes after drug ingestion. At one-week interval, 
subjects’ baseline pain thresholds were recorded and they were given the other brand of 
the drug. Pain thresholds were recorded at 30,60, 90 and 120 minutes intervals. The data 
were analysed using the SPSS for windows (Release 9.0 version), p-value ≤ 0.05 was 
considered significant. Results: Age and gender did not have any significant effect on the 
baseline or mean scores for both drugs. Overall, Panadol® and Panadol -Extra® 
individually demonstrated significant differences in tooth sensitivity when compared with 
the baseline. A comparison of the effects of both drugs however showed no significant 
difference in their effects on dental pain perception. Conclusion: Although both drugs 
had significant therapeutic effects on baseline dental pain perception, a comparison of 
their effects showed no significant difference in their effects on the pain. 
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INTRODUCTION  
Pain is the most prominent symptom of 
diseases in man and analgesics are the 
most widely used drugs1.  More than 
90% of the analgesics being used belong  
to the so-called peripheral acting, non-
opiod (non-narcotic) or mild analgesics.  
They are all derived from three types of 
compounds: aspirin and other acidic 
non-steroidal anti-inflammatory drugs 
(NSAIDs), aniline derivatives such as 
paracetamol (acetaminophen) and non-
acidic pyrazole drugs like propyhenozole 
and dipyrone (metamizole)1. 
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Analgesics are known to influence the 
transmission of pain impulses through 
the sensory pathways (Figure 1).  
 
Figure 1. The pathway of pain fibres of 




The analgesic action of a drug can be 
peripheral, central or both.  A peripheral-
acting analgesic such as aspirin, acts 
directly at the site of origin of pain to 
control it. This is done through anti-
inflammatory effect or by vasodilatation. 
The central - acting drugs e.g. morphine 
act directly on the central nervous 
system (CNS) by inhibiting afferent 
activity or depression of the central 
mechanism. Such drugs may occupy the 
receptor sites to effect analgesia2 .  
Paracetamol (acetaminophen) has both 
peripheral and central actions.  Its 
mechanism of action is poorly defined 
however, it has been speculated that it 
selectively inhibits prostaglandin 
production in the CNS, which would 
account for its analgesic effect.  
Although a reasonably good antipyretic, 
it has very little anti-inflammatory 
activity3. Paracetamol is a valuable 
analgesic and anti-pyretic agent.  
 
It is useful in the treatment of pain from 
everyday causes and for febrile 
infections with musculoskeletal pain, 
toothache or headache. It is practically 
problem-free when used correctly, 
however; its overdosage may cause 
hepatic damage. A dose of 8 to 10gm 
can be fatal in adult.  In children the life 
threatening dose range from 2 to 8gm, 
depending on age, and in infants, only 
0.5gm3. "Panadol® and Panadol-Extra® 
are registered trade names for 
Paracetamol 500mg B.P. and 
Paracetamol 500mg with Caffeine 30mg 
respectively. They are produced by 
SmithKline Beecham Drug Company. 
They are brands of Paracetamol and 
Panadol-Extra® is a combination drug. 
The use of two or more analgesics in 
combination (analgesic combination) is 
reasonable if their effects and their 
pharmacokinetics harmonize with one 
another. Caffeine is an alkaloid stimulant 
found in tea leaves and coffee beans4. 
 
Cafffeine and other methylxanthines are 
believed to increase the absorption of 
acetylsalicylic acid in man.  Similarly, 
simultaneous ingestion of phenacetin 
with caffeine not only delays the 
breakdown of caffeine but also 
potentates its effect 4 . Some bases for 
using caffeine in combination with 
analgesics may perhaps be found in the 
demonstrable efficacy of caffeine in 
migraine and headaches, an effect that 
may be due to its intrinsic power of 
raising vessel tone in the cranial area.  A 
case can even be made for combining 
caffeine with paracetamol 5."Panadol-
Extra®" believed to be an improvement 
on "Panadol®”, is an analgesic 
combination of Paracetamol 500mg BP 
and Caffeine 30mg. Its analgesic 
efficacy is expected to be superior to 
Panadol® (Paracetamol 500mg B.P). 
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This study therefore sets out to evaluate 
and compare the therapeutic effects of 
"Panadol®" and "Panadol-Extra®" on 
experimentally induced dental pain in 
healthy volunteers. 
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SUBJECTS AND METHODS 
Twenty healthy volunteers (10 females 
and 10 males) with age range 17 to 44 
years were used for this study.  The 
volunteers were mainly Students and 
Staff of the Dental Hospital, Obafemi 
Awolowo University Teaching 
Hospitals’ Complex, Ile-Ife, Nigeria. 
The criteria for selection for the study 
include the possession of healthy 
maxillary incisors, not previously 
restored in adults with no history of 
previous reaction to paracetamol or 
caffeine.  The procedures of the study 
were explained to the volunteers and 
were assured of their safety after which 
their consents were obtained.  The 
volunteers were expected to attend the 
two stages of the study carried out by 
only one of the authors (OO).   
 
At the first visits, the volunteers were 
comfortably seated on dental chairs; 
their maxillary incisors were dried and 
isolated with gauze.  With the aid of a 
Digitest Pulp Vitality Tester (Model No. 
D6260) by Parkell Electronics Division, 
Farmingdale NY 11735, (Figure 2) 
which was used as the stimulator, the 
pain thresholds on the right maxillary 
incisors were detected in all the 
volunteers. The tip of the sterile 
removable probe on the stimulator was 
smeared with some toothpaste, which 
acted as the conduction gel. The same 
brand of toothpaste was used for all the 
volunteers. 
 
Obtaining the pain threshold involved 
applying the tip of the stimulator on the 
dried labial surface of the right maxillary 
incisor and stimulation was set on by 
continuously pressing on the button on 
the appliance with an ungloved hand. 
The stimulating intensity increased from 
zero to a maximum of 64 units.   
 
Figure 2. Shows a digitest vitality tester 



















     
 
 
The subject was expected to indicate by 
lifting up an index finger the moment he 
or she had the slightest sensation on the 
tooth.  The button was then released and 
the intensity was read off from the tester. 
The reading appeared on the digital 
display for a few seconds before it 
disappeared. This was the pain threshold 
or baseline reading. The subjects were 
then randomly given 1000mg 
paracetamol (2 tablets of Panadol®) or 
1000mg paracetamol and 60mg of 
Caffeine (2 tablets of Panadol- Extra) to 
ingest, single blind. Thirty minutes after 
the drug ingestion, the detection of pain 
threshold was repeated (P30 or X30).  
The same procedure was repeated after 
60, 90 and 120 minutes post ingestion.  
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Subjects were recalled after one week 
for the second stage of the study during 
which they took the other brand of 
Paracetamol and the whole procedure 
was repeated recording the pain 
threshold at the stipulated time interval. 
The subject was not expected to ingest 
any brands of paracetamol during the 
one-week interval so as not to cause any 
interference with the study. All the data 
were recorded and analysed using the 
SPSS for windows (Release 9.0 version), 




A logistic regression of the data showed 
that gender (sex) and age did not have 
any significant effect on either the 
baseline or mean scores for both 
Panadol® and Panadol-Extra®.   
 
Tables 1 and 2 show that for Panadol®, 
there were significant differences in 
tooth sensitivity at baseline (Wilcoxon 
Signed Ranks Text) compared with 
measurements taken at 30 mins (Z = - 
2.416, P = 0.010), 60 mins (Z = - 2.644, 
P = 0.008), 90 mins (Z = - 2.713, P = 
0.006) and 120 mins (Z = - 2.699, P = 
0.007). The overall effect of Panadol® 
was also found to be significant using 
Friedman's test (P = 0.001).  Similarly 
for Panadol-Extra®, there were 
significant differences in tooth 
sensitivity at baseline (Wilcoxon Signed 
Ranks Test) compared with 
measurements taken at 30 mins (Z = - 
3.379, P = 0.01), 60 minutes (Z = - 
3.558, P = 0.00), 90 mins (Z = - 3.837, P 
= 0.00) and 120 mins (Z = - 3.442, P = 
0.001).  The overall effect of Panadol-
Extra® was also found to be significant 
using Friedman's test (P = 0.00).  When 
Panadol® was compared with Panadol-
Extra®, no significant differences were 
observed at baseline (Z = - 0.26, P = 
0.026), 30 mins. (Z = - 1.431, P = 0.153) 
60 mins. (Z = - 1.930, P = 054), 90 mins. 
(Z = - 1.403, P = 1.61) and at 120 mins. 





Table 1.  Effect of the gender on drug action 
Variable (Gender)         B      SE        Wald        df     Sig 
Panadol-Mean  0.3921    0.3169    1.5311         1     0.2160 
Panadol-Extra-Mean  0.0154    0.2620   0.003C         1    0.9534 
Baseline-Pan Ext  0.1821    0.4751   0.146C         1    0.7015 
Baseline-Pan  0.3409      .3156    1.1671         1    0.2800 
Constant  0.0368    1.7120    0.0005         1    0.9828 
Table 2.  Effect of age on drug action 
Variable (Age) B S.E. Wald df Sig 
Panadol – Mean 0.0352 0.2617 0.0181 1 0.8929 
Panadol Extra Mean  0.1913 0.2506 0.5828 1 0.4452 
Baseline- Panadol Extra 0.0807 0.4366 0.0304 1 0.8617 
Baseline- Panadol 0.1616 0.2702 0.3576 1 0.5498 
Constant 0.3376 1.7552 0.0370 1 0.8475 
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DISCUSSION 
This study showed that the age and sex 
of the subjects did not have any 
significant effect on the analgesic 
functions of Panadol® and Panadol-
Extra®. Similarly, in a study on the 
search for sex differences in response to 
analgesia, Averbuch and Katzper6 
reported that gender had no effect on 
analgesic response to ibuprofen, a mild 
analgesic like Panadol® or Panadol-
Extra®. This was irrespective of the 
generally accepted view that males and 
females respond differently to painful 
conditions and that females demonstrate 
a lower pain threshold and a lower 
tolerance of painful stimuli. Females 
were also reported to have experienced 
greater analgesic efficacy than do males 
after the administration of narcotic 
analgesics6. 
 
Our finding that age had no effect on the 
analgesic function of Panadol ®and 
Panadol-Extra® support the various 
reports in the literature that paracetamol 
equally relieved mild to moderate pain in 
children as well as in adults7-10. 
Panadol® was found to have produced 
significant differences in tooth 
sensitivity at baseline compared with 
measurements taken at 30, 60, 90 and 
120 minutes.   
 
The differences were most prominent at 
90 and 120 minutes post-ingestion of the 
drug.  Similarly, Panadol-Extra® 
produced significant differences in tooth 
sensitivity at baseline compared to 
measurements taken at 30, 60, 90 and 
120 minutes and the differences were 
most prominent at 60 and 90 minutes 
post-ingestion of drug. This study  
 
therefore confirmed the analgesic 
efficacy of paracetamol (acetaminophen) 
for mild to moderate pain as already 
proposed by experts, 3,7,11,12. However in 
severe pain, paracetamol could offer a 
significant additive analgesic effect to 
the opiates7 .  It has been speculated that 
paracetamol selectively inhibit 
prostaglandin production in the CNS, 
which could account for its analgesic 
effect3,12. 
 
When Panadol® was compared with 
Panadol -Extra® (an analgesic 
combination of paracetamol 500mg B.P. 
and caffeine 30mg) no significant 
differences were observed at baseline, 
30, 60, 90 and 120 minutes post - 
ingestion of drugs.  The combination of 
paracetamol and caffeine was proposed 
by Laska et al5. Caffeine is believed to 
be capable of potentiating the effect of 
an analgesic by increasing its 
absorption4 hence Panadol-Extra® is 
expected to be a more potent analgesic 
than Panadol®. 
 
This study however showed that even 
with the combination of caffeine with 
paracetamol in Panadol-Extra®, its 
analgesic effect in relieving dental pain 
was not significantly different from that 
of Panadol® (Paracetamol).  
 
CONCLUSION 
Panadol® and Panadol-Extra® had 
significant effects on the relief of dental 
pain. However, when their effects were 
compared, Panadol-Extra® did not seem 
to have any significant superior effect on 





Http:// www.ajoh.org  © African Journal of Oral Health.  
   
29
Therapeutic effects of paracetamol – Fagade & Oginni  African Journal of Oral Health 




1. Brune K. Comparative 
Pharmacology of non-opoid 
analgesics.  Medical Toxicology 
1986; 1(Supp 1), 1. 
2. Fagade OO. and Wastell DG. 
Comparative study of Aspirin and 
Temgesic on long - latency 
trigeminal evoked Potentials.  Nig. 
Medical Jour. 1995; 28,122 - 126. 
3. Jackson CH, MacDonald NC and 
Cornett JWD. Acetaminophen. 
Canadian Med. Assoc. J.1984; 
131,25- 37. 
4. Collins C, Richards P.T., Starmer 
G.A. Caffeine -Phenacetine 
interaction in the rat: effects on 
absorption, metabolism and 
locomotor activity J. Pharm. 
Pharmaac.1977; 29,217-221. 
5. Laska EM. et al. Effect of caffeine 
as an analgesic adjuvant J.  Am. 
Med. Assoc.1984; 251,1711-1718. 
6. Averbuch M and Katzper M. A 
search for sex differences in          
response to analgesia.  Arch Intern. 
Med.2000;160,3424-3430. 
7. Cranswick N. and Coghlan D. 
Paracetamol efficacy and safety in 
children: the first 40 years.  Am. J. 


















8. Moller PL  Norholt SE, Ganry HE, 
Insuasty JH, Vincent FG, Skoglund 
LA and Sinde-Pedersen S. Time to 
onset of analgesia. Efficacy of 
effervescent acetaminophen 1000mg 
compared to tablet Acetaminophen 
1000mg In: Post-operative dental 
pain: a single-dose, double-blind, 
randomized placebo - controlled 
study. J. Clin. Pharmacol. 
2000;40,370-378. 
9. Kacso G. and Terezhalmy GT. 
Acetysalicylic acid Acetaminophen 
Dent. Clin North Am.1994;38,633-
641. 
10. Korberly BH; Schreiber GF;  
Kilkuts A. Orkand RK and Segal H 
Evaluation of acetaminophen and 
aspirin in the relief of post-operative 
dental pain J. Am. Dent. 
Assoc.1980;100,39-49. 
11. Quellet. M. and Percival MD. 
Mechanism of  acetaminophen 
inhibition of cyclo-oxygenase 
isoforms. Arch. Biochem. 
Biophys.2001; 387,273-280. 
12. Ramwell PW. Biological importance 
of arachinodic acid.  Arch. Int. 
Medicine.1981;141,275-284. 
Http:// www.ajoh.org  © African Journal of Oral Health.  
 
30
